| Public title (as per ICTRP) | Scientific title (as per ICTRP) | Trial identifier |
|---|---|---|
| Pyridoxine-pyrrolidone carboxylate (Metadoxine) for the treatment of metabolic dysfunction associated steatotic liver disease and increased alcohol intake (MetALD) | Pyridoxine-pyrrolidone carboxylate (Metadoxine) for the treatment of metabolic dysfunction associated steatotic liver disease and increased alcohol intake (MetALD) | TCTR20250322001 |
| NMP in Relapsed / Refractory Myeloma | A Phase I, Open Label Dose Escalation Trial of Orally Administered N-methyl-pyrrolidone (NMP) in Patients With Relapsed or Refractory Myeloma | NCT02468687 |
